2m 2m 2m 2m 2m 2m 2m
OVID THERAPTCS (OVID)
NASDAQ
$2.81+$0.005 (+0.18%)
Price as of Aug 21, 2026 7:59 PM EDT- $546.8MMarket Cap
- 171.84%1-Year Change
- BiotechnologyIndustry
OVID THERAPTCS (OVID)
$2.81+$0.005 (+0.18%)
OVID | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.80 | ||
Change | +$0.06 (+2.19%) | ||
Open | $2.76 | ||
High | $2.83 | ||
Low | $2.71 | ||
Previous Close | $2.74 | ||
Volume | 1,331,917 | ||
30-Day Average Volume | 1,578,244 | ||
1-Week Change | -1.06% | ||
1-Month Change | 16.18% | ||
1-Year Change | 171.84% | ||
3-Year Change | -28.84% | ||
5-Year Change | -20.23% | ||
Fundamentals | |||
Shares Outstanding | 195.3M | ||
Total Assets | $232.0M | ||
Market Cap | $546.8M | ||
Enterprise Value | $535.5M | ||
Period: QTR TTM FY | |||
Revenue | $733,000.00 | ||
Net Income | -$15.0M | ||
Free Cash Flow | -$17.6M | ||
EBIT | -$15.0M | ||
EBITDA | -$15.0M | ||
Net Working Capital | $113.6M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | 731 | ||
P/B | 3 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -31 | ||
Price/Operating Cash Flow | -31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue